Evaluation of a novel glass vial overcoming adsorption effect for pharmaceutical drugs

Significance of the topic

Adsorption of drug molecules onto sample vials during HPLC and LC/MS analysis can lead to significant losses, compromising accuracy and precision. As sensitivity requirements increase with modern instrumentation, trace-level quantification becomes more vulnerable to surface interactions. Developing vial materials with minimal adsorption is therefore critical for reliable pharmaceutical analysis, especially for basic and hydrophobic compounds at low concentrations.

Objectives and study overview

This study evaluated a novel glass vial, the LabTotal Vial, designed to minimize adsorption of pharmaceutical compounds. Key aims were to compare its inertness against commercially available vials, assess performance for ultratrace analysis, and investigate the vial surface at micro- and nano-scales to elucidate the adsorption mechanism.

Methodology and used instrumentation

The evaluation involved four basic drugs (amitriptyline, atenolol, imipramine, propranolol) and one amphiphilic compound (amiodarone). Stock solutions (1 mg/L) and ultratrace standards (0.05 µg/L) were prepared in water or mobile phase. Chromatographic separation used Shim-pack XR-ODS columns with 0.1% TFA in water and acetonitrile as mobile phases under gradient conditions. Analyses were performed on a Shimadzu Nexera MP HPLC system with an SPD-M30A photodiode array detector and LCMS-8060 triple quadrupole mass spectrometer. Surface characterization of vials employed Nano Search Microscope SFT-4500 (LSM) and atomic force microscopy (AFM).

Main results and discussion

• The LabTotal Vial achieved 100% recovery for all four basic compounds, outperforming Vendor A (85–97% recovery) and Vendor B (37–84%).
• In 0.05 µg/L trace analysis, peak areas in the LabTotal Vial were nearly double those in Vendor A vials, demonstrating superior sensitivity retention.
• For amiodarone, which combines basic and hydrophobic properties, LabTotal Vial recovery was 6216 mAU compared to ~1700 mAU in standard glass and polypropylene vials, indicating broad inertness.
• Surface imaging revealed that LabTotal Vials have exceptionally smooth micro- and nanoscale topography, while conventional vials exhibit rough surfaces with nanoscale pits likely trapping analytes.

Benefits and practical applications

By virtually eliminating adsorption losses, the LabTotal Vial enhances quantitative accuracy and precision in pharmaceutical HPLC and LC/MS workflows. Its performance is particularly advantageous for low-concentration assays, multicomponent samples with diverse properties, and analyses of unknown compounds where material interactions pose unpredictable biases.

Future trends and potential applications

• Integration with next-generation ultra-high sensitivity mass spectrometers to further lower detection limits.
• Adaptation for bioanalytical assays involving peptides, proteins, and highly lipophilic drug candidates.
• Development of standardized inert vial screening protocols across laboratories to ensure consistent data quality.
• Potential expansion into automated sample preparation systems and microfluidic platforms where surface interactions are critical.

Conclusion

The LabTotal Vial demonstrates superior inertness across a range of pharmaceutical compounds and concentrations, attributable to its smooth micro/nanostructure. It represents a robust solution for high-precision quantitative analysis in HPLC and LC/MS applications, addressing a persistent challenge in trace-level pharmaceutical testing.

Reference

Minori Nakashima et al. Evaluation of a novel glass vial overcoming adsorption effect for pharmaceutical drugs. Shimadzu Application Note PO-CON1577E, June 2015.